Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05421858 | A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | ||
| NCT05527834 | Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants | ||
| NCT02490800 | Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma | ||
| NCT03439124 | Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia | ||
| NCT01582425 | Drug Interaction Study of Isavuconazole and Methadone | ||
| NCT00309621 | Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis | ||
| NCT02527681 | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics | ||
| NCT06733675 | Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination | ||
| NCT00210899 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | ||
| NCT06665555 | Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age | ||
| NCT05488678 | Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function | ||
| NCT04166669 | A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 | ||
| NCT00229008 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT01809860 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects | ||
| NCT01565720 | Study of the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization | ||
| NCT01555918 | A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers | ||
| NCT00326287 | Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia | ||
| NCT01407679 | Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus | ||
| NCT01813461 | Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects | ||
| NCT06808646 | A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin | ||
| NCT02128321 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine | ||
| NCT06925321 | A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. | ||
| NCT06961708 | A Study of Fosmanogepix in Healthy Adult Chinese Subjects | ||
| NCT00505258 | Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia | ||
| NCT01884636 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate | ||
| NCT00770978 | Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU | ||
| NCT05491733 | A Bioequivalence Study of APX001 High-load and Low-load Tablets | ||
| NCT03138733 | Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia | ||
| NCT00817063 | Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema | ||
| NCT03333005 | Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia | ||
| NCT01657825 | Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects | ||
| NCT07500181 | A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects | ||
| NCT01582412 | Drug Interaction Study of Isavuconazole and Digoxin | ||
| NCT04148287 | An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris | ||
| NCT00634049 | Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi | ||
| NCT01397929 | An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors | ||
| NCT01555866 | Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole. | ||
| NCT04314206 | VNRX-5024 Safety and PK in Healthy Adult Volunteers | ||
| NCT00413439 | Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | ||
| NCT01657838 | Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects | ||
| NCT04087876 | Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations | ||
| NCT01635946 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin | ||
| NCT02128893 | A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole | ||
| NCT05856227 | Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age | ||
| NCT04604132 | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma | ||
| NCT01026558 | A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients | ||
| NCT04098692 | Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects | ||
| NCT04243863 | VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers | ||
| NCT03250299 | Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | ||
| NCT02895360 | Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma |
